


| Key | % Net Assets | 
|---|---|
| 5.7% | |
| 5.6% | |
| 4.4% | |
| 3.8% | |
| 80.5% | 
| Name | % Net Assets | 
|---|---|
| GlaxoSmithKline | 5.7% | 
| Royal Dutch Shell | 5.6% | 
| Vodafone | 4.4% | 
| British American Tobacco | 3.8% | 
| Unilever | 2.9% | 
| AstraZeneca | 2.8% | 
| BT Group | 2.7% | 
| Imperial Tobacco | 2.7% | 
| HSBC Holdings | 2.5% | 
| Centrica | 1.9% | 
No asset data available.
| Date | 09-May-2022 | 
|---|---|
| NAV | 115.40p | 
| Currency | GBP | 
| Change | -2.60p | 
| % | -2.20% | 
| YTD change | 115.40p | 
| YTD % | n/a | 
| Fund Inception | 18/10/2004 | 
|---|---|
| Fund Manager | n/a | 
| TER | - | 
| Minimum Investment | |
|---|---|
| Initial | n/a | 
| Additional | n/a | 
| Savings | n/a | 
| Charges | |
|---|---|
| Initial | n/a | 
| Annual Mang't | 1.70% | 
| Exit | n/a | 
| Name | % | 
|---|---|
| No risk data available. | |
You are here: research